Insider · CIK 0001231945

DUBIN THOMAS I H

Reports to the SEC for 3 companies · SHELTON, CT

sec.gov

Transactions

Companies

Filings

CIK

0001231945

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+5,500 sh	—	—	5,500
2025-05-02	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+50K sh	—	—	50,000
2024-05-14	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+50K sh	—	—	50,000
2024-05-08	Notable Labs, Ltd.A Award	Director	AAward	+40.2K sh	—	—	40,247
2024-01-24	Notable Labs, Ltd.Stock OptionA Award	Director	AAward	+9,753 sh	—	—	9,753
2012-08-23	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−9,200 sh	$103.87	−$956K	65,705
2012-08-23	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−24.3K sh	$103.09	−$2.51M	74,905
2012-07-31	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−680 sh	$104.94	−$71.4K	99,233
2012-07-27	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−68.6K sh	$108.56	−$7.45M	128,781
2012-07-27	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+56.3K sh	$22.90	+$1.29M	239,502
2012-07-27	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−668 sh	$106.14	−$70.9K	99,913
2012-07-27	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	60,000
2012-07-27	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+82.7K sh	$17.98	+$1.49M	183,252
2012-07-27	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−51.3K sh	$107.57	−$5.52M	197,413
2012-07-27	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−6,268 sh	$105.76	−$663K	265,358
2012-07-27	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−82.7K sh	—	—	12,751
2012-07-27	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−56.3K sh	—	—	43,750
2012-07-27	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+28.1K sh	$42.66	+$1.2M	267,626
2012-07-27	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+4,000 sh	$78.88	+$316K	271,626
2012-07-27	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−28.2K sh	$109.28	−$3.08M	100,581
2012-07-27	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−16.6K sh	$106.35	−$1.77M	248,716
2012-07-27	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−28.1K sh	—	—	61,876
2012-06-15	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−6,578 sh	—	—	95,422
2012-06-15	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−36K sh	—	—	0
2012-06-15	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−9,011 sh	$94.04	−$847K	100,581
2012-06-15	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−33.6K sh	$93.96	−$3.15M	109,591
2012-06-15	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+6,578 sh	$17.98	+$118K	143,159
2012-06-15	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+36K sh	$17.65	+$635K	136,581
2012-05-29	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−39K sh	—	—	36,000
2012-05-29	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−44.3K sh	—	—	0
2012-05-29	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−20.1K sh	—	—	0
2012-05-29	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+39K sh	$17.65	+$688K	203,981
2012-05-29	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+44.3K sh	$11.91	+$528K	164,981
2012-05-29	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+20.1K sh	$10.29	+$207K	120,673
2012-05-29	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−103K sh	$92.02	−$9.51M	100,581
2012-05-14	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+18.1K sh	$8.18	+$148K	100,581
2012-05-14	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−18.1K sh	—	—	0
2012-05-10	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−9,908 sh	—	—	0
2012-05-10	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−5,692 sh	—	—	0
2012-05-10	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+5,692 sh	$11.92	+$67.8K	77,493
2012-05-10	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+5,000 sh	$17.65	+$88.3K	82,493
2012-05-10	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−5,000 sh	—	—	0
2012-05-10	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+9,908 sh	$10.29	+$102K	71,931
2012-03-14	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+24K sh	$6.90	+$166K	86,023
2012-03-14	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−20K sh	—	—	20,092
2012-03-14	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−21.9K sh	—	—	0
2012-03-14	ALEXION PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	−24K sh	—	—	0
2012-03-14	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−11.2K sh	$89.24	−$999K	62,023
2012-03-14	ALEXION PHARMACEUTICALS, INC.S Sale	SVP & Chief Legal Officer	SSale	−54.7K sh	$88.72	−$4.85M	73,233
2012-03-14	ALEXION PHARMACEUTICALS, INC.M Exercise/Conversion	SVP & Chief Legal Officer	MExercise/Conversion	+20K sh	$10.29	+$206K	127,935

Recent filings

Accepted (ET)
Jul 204
DUBIN THOMAS I H0001231945-26-000002
SEC(opens sec.gov)
May 64
DUBIN THOMAS I H0001567264-25-000033
SEC(opens sec.gov)
May 154
DUBIN THOMAS I H0001567264-24-000019
SEC(opens sec.gov)
May 104
DUBIN THOMAS I H0001062993-24-009933
SEC(opens sec.gov)
Jan 264
DUBIN THOMAS I H0001062993-24-001359
SEC(opens sec.gov)
Aug 274
DUBIN THOMAS I H0001231977-12-000069
SEC(opens sec.gov)
Jul 314
DUBIN THOMAS I H0001231977-12-000065
SEC(opens sec.gov)

Companies

Address

C/O INTENSITY THERAPEUTICS, INC. 1 ENTERPRISE DRIVE, SUITE 430

SHELTON, CT, 06484